Pfizer mini oral: ATTR-CM: Local research, Clinical Relevance
| Saturday, August 8, 2026 |
| 10:00 AM - 10:30 AM |
| Theatrette 4 (Exhibition Hall) |
Details
Dr Daniel Chen will lead a focused discussion with Dr Paul Geenty and Ms Elyn Montgomery, Clinical Nurse Consultant, on emerging local insights in ATTR‑CM.
Dr Geenty will present new data on the prevalence of ATTR‑CM in Australia, while Ms Montgomery will highlight the critical role of frailty assessment in optimising patient management.
An interactive session with opportunities for audience engagement and discussion.
Speaker
Dr Paul Geenty
Cardiology Fellow
Westmead Hospital
ATTR-CM: Local research, Clinical Relevance
10:00 AM - 10:30 AMBiography
Paul is a cardiology fellow at Westmead Hospital, and is currently enrolled in a PhD at the University of Sydney.
Dr Elyn Montgomery
Postdoctoral Researcher
Victor Chang Cardiac Research Institute
ATTR-CM: Local research, Clinical Relevance
10:00 AM - 10:30 AMBiography
Dr Elyn Montgomery is a nurse academic and clinician, Lecturer at the University of Technology Sydney, and coordinator of the amyloidosis service at St Vincent’s Hospital Sydney. Her research bridges cardiovascular nursing, frailty, and cardiac amyloidosis, advancing deep phenotyping and patient centered care. She collaborates with the Victor Chang Cardiac Research Institute and the Australian Amyloidosis Network. Elyn is committed to translating evidence into guidelines and pathways that improve outcomes for people with complex cardiovascular disease.
